TGA
PCVX icon

TPG GP A’s Vaxcyte PCVX Stock Holding History

TPG GP A’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,190,336
Closed -$44.6M – 42
2023
Q1 		$44.6M Hold
1,190,336
– – 0.73% 27
2022
Q4 		$57.1M Sell
1,190,336
-2,095,168
-64% -$82.2M 1.12% 24
2022
Q3 		$78.9M Sell
3,285,504
-381,921
-10% -$9.68M 1.29% 20
2022
Q2 		$79.8M Sell
3,667,425
-387,667
-10% -$8.97M 1.23% 20
2022
Q1 		$97.9M Sell
4,055,092
-152,483
-4% -$3.33M 1.21% 21
2021
Q4 		$100M Buy
+4,207,575
New +$97.9M 1% 23

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TPG GP A's PCVX Position: Q2 2023 in Review

TPG GP A sold out of Vaxcyte (PCVX) in Q2 2023, closing a stake of 1,190,336 shares — an estimated $44.6M sold.

TPG GP A first reported a position in PCVX in Q4 2021 and held it in 6 quarters. The position peaked at $100M in Q4 2021. 197 funds tracked by Wall St. Rank hold PCVX as of Q2 2023.

  • TPG GP A reported no remaining Vaxcyte position as of Q2 2023 after selling out during the quarter.
  • TPG GP A sold 1,190,336 Vaxcyte shares in Q2 2023, an estimated $44.6M.
  • TPG GP A first reported a position in Vaxcyte in Q4 2021 and held it in 6 quarters.
  • TPG GP A's Vaxcyte position peaked at $100M in Q4 2021.
  • 197 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2023.

Based on TPG GP A's 13F filing for Q2 2023, filed 14 Aug 2023.